Ueda, Y., Ishii, H., Kitano, T., Shindo, M., Miyazawa, H., Ito, K., Hirai, K., Kaku, Y., Mori, H., Hoshino, T., Ookawara, S., Kakei, M., Tabei, K. and Morishita, Y. 2016. Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers. Drug Target Insights. 10, 1 (Sep. 2016). DOI:https://doi.org/10.33393/dti.2016.1422.